Authors: Vergani, A.; Clissi, B.; Sanvito, F.; Doglioni, C.; Fiorina, P.; Pardi, R.

Source: Cell Transplantation, Volume 18, Number 8, 2009 , pp. 827-832(6)

Publisher: Cognizant Communication Corporation

Abstract:

Innovative tolerogenic protocols in transplantation would take advantage of the development of new tools capable of evaluating the impact of these treatments on the immune system. These assays have potential for clinical application. Currently, many of these studies are based on the analysis of peripheral lymph nodes and blood-derived cells, where the percentage of alloantigen-specific cells can be low or even unpredictable. We combined a laser capture microdissection (LCM) technique with real-time PCR (RT-PCR) to evaluate gene profile of islet-infiltrating lymphocytes. Donor Lewis rats islets were transplanted under the kidney capsule in diabetic Brown Norway rats. Administration of anti-LFA1 mAb or anti-CD28 F(Ab)′ was able to prolong islet survival, while the combined treatment resulted in indefinite survival. The analysis of gene expression profile for IL-2, IFN-γ, and IL-10 production of graft-infiltrating cells revealed high IL-2, IFN-γ, and IL-10 in untreated rats; on the contrary, the combined treatment selectively abrogated IL-2- and IFN-γ-producing cells infiltrate. The comparison between cytokine profile in periphery (even during an allogenic extra stimulus) and in the graft revealed the dichotomy between graft and peripheral cytokine assessment. We thus propose that direct analysis of graft-infiltrating cells should be used whenever possible to evaluate the effects of a new immunomodulatory protocol.

References: 16 references open in new window

Articles that cite this article?

Keywords: Islet transplantation; Laser capture microdissection (LCM); Gene expression; Graft-infiltrating lymphocytes; Costimulation blockade

Document Type: Research article

DOI: http://dx.doi.org/10.3727/096368909X472278

Affiliations: 1: Transplantation Research Center(TRC)-Nephrology, Children's Hospital-Harvard Medical School, Boston, MA, USA; Department of Biological and Technological Research, Scientific Institute San Raffaele, Milan, Italy

Publication date: 2009-08-01

More about this publication?

• Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
  

Related content

• In this: publication
• By this: publisher
• In this Subject: Anatomy & Physiology ,  Biology ,  Biotechnology ,  Pharmacology ,  Surgery
• By this author: Vergani, A. ;  Clissi, B. ;  Sanvito, F. ;  Doglioni, C. ;  Fiorina, P. ;  Pardi, R.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers